To properly inject Innotox 100u for nasal scrunch treatment, you need to understand that this is a specialized cosmetic procedure that involves injecting botulinum toxin type A into specific muscles around the nose to reduce the appearance of nasal scrunching, wrinkles, and to create a smoother nasal profile. The procedure requires precise anatomical knowledge, correct dosage calculation (typically 2-4 units per injection point), proper reconstitution with sterile saline, and careful injection technique targeting the nasalis muscle and surrounding depressor muscles.
Understanding Nasal Scrunch Treatment and Its Mechanism
Nasal scrunch treatment, also known as nasal botulinum toxin injection or “bunny line” treatment, addresses the dynamic wrinkles that appear on the sides of the nose when you smile, laugh, or scrunch your face. These wrinkles form due to the contraction of the nasalis muscle and the transverse portion of the nasalis muscle, which compresses the nasal bridge and creates horizontal lines across the nose.
Key Anatomical Structures:
- Nasalis muscle (transverse head) – Primary target for treatment, responsible for nasal compression
- Nasalis muscle (alar head) – Controls flare of the nostrils
- Depressor septi nasi muscle – Pulls the nose tip downward when smiling
- Levator labii superioris alaeque nasi – Elevates the upper lip and nasal ala
What is Innotox 100u?
innotox 100u is a liquid formulation of botulinum toxin type A manufactured by Medytox in South Korea. Unlike traditional powdered botulinum toxin products that require reconstitution, Innotox comes pre-mixed in a 100-unit vial, making it more convenient for practitioners and reducing preparation errors.
This product has gained popularity in aesthetic medicine due to several distinguishing characteristics that set it apart from other botulinum toxin formulations on the market.
Advantages of Using Innotox 100u for Nasal Treatment
| Feature | Innotox 100u | Traditional Botulinum Toxins |
|---|---|---|
| Formulation | Ready-to-use liquid | Powder requiring reconstitution |
| Storage | Room temperature (2-25°C) | Refrigerated storage required |
| Shelf life after opening | Up to 48 hours | Typically 24 hours |
| Protein load | Lower foreign protein content | Higher protein content |
| Diffusion characteristics | Moderate spread radius | Varies by formulation |
Pre-Procedure Preparation and Patient Assessment
Before proceeding with Innotox 100u injection for nasal scrunch treatment, a thorough patient evaluation is essential. This assessment ensures treatment safety and optimizes outcomes.
Patient Selection Criteria
- Patients with moderate to severe dynamic nasal wrinkles when smiling or laughing
- Individuals with good overall health without neuromuscular disorders
- Patients not currently pregnant or breastfeeding
- No active skin infections in the treatment area
- Realistic expectations about treatment outcomes
- No known allergy to botulinum toxin products
Contraindications to Consider
- Absolute contraindications:
- Neuromuscular disorders (myasthenia gravis, Lambert-Eaton syndrome)
- Allergy to any botulinum toxin formulation
- Active infection at injection site
- Pregnancy or lactation
- Relative contraindications:
- Facial asymmetry
- Previous surgery in the nasal area
- Use of aminoglycoside antibiotics or muscle relaxants
- Bleeding disorders or anticoagulant therapy
Reconstitution Guidelines for Innotox 100u
Although Innotox comes as a ready-to-use liquid formulation, some practitioners prefer to further dilute it for more precise dosing in delicate areas like the nose. Understanding proper dilution ratios ensures accurate dosing.
| Treatment Area | Dilution Ratio | Final Concentration | Volume per Unit |
|---|---|---|---|
| Nasal scrunch (standard) | Undiluted (as provided) | 4 units/0.1mL | 0.025mL per unit |
| Nasal scrunch (diluted for precision) | 1:1 with saline | 2 units/0.1mL | 0.05mL per unit |
| Fine lines (extra precision) | 1:2 with saline | 1.33 units/0.1mL | 0.075mL per unit |
Important Note: When diluting Innotox 100u, use only sterile 0.9% sodium chloride injection (preservative-free saline is preferred for cosmetic injectables). The dilution should be performed using aseptic technique within the treatment room to maintain product sterility.
Step-by-Step Injection Technique
The injection technique for nasal scrunch treatment with Innotox 100u requires precision and understanding of nasal anatomy to achieve optimal results while minimizing risks.
Injection Points and Dosing
| Injection Point | Anatomical Landmark | Dosage (units) | Needle Depth |
|---|---|---|---|
| Point 1 (right) | Nasal dorsum, lateral to midline | 2-3 units | 2-3mm (intradermal/subcutaneous) |
| Point 2 (left) | Nasal dorsum, lateral to midline | 2-3 units | 2-3mm (intradermal/subcutaneous) |
| Point 3 (right) | Above nasofacial fold | 1-2 units | 2-3mm (intradermal) |
| Point 4 (left) | Above nasofacial fold | 1-2 units | 2-3mm (intradermal) |
| Total per treatment | — | 6-10 units | — |
Detailed Procedure Steps
- Patient Positioning:
- Position the patient in an upright sitting position at approximately 70-80 degrees
- Have the patient perform a full smile and scrunch to identify dynamic wrinkle patterns
- Mark injection points with a surgical marker while the patient is smiling
- Sterile Preparation:
- Clean the nasal area with alcohol swab or chlorhexidine solution
- Allow the area to dry completely
- Consider applying topical anesthetic cream 15-20 minutes before injection if patient is sensitive
- Injection Technique:
- Use a 30-gauge or 31-gauge insulin syringe for precision
- Insert needle at a 15-30 degree angle, bevel facing up
- Inject into the superficial subcutaneous layer or intradermal layer
- Use a quick, controlled injection to minimize discomfort
- Apply gentle pressure with gauze after injection to minimize bruising
- Post-Injection Assessment:
- Evaluate symmetry immediately after injection
- Document the exact injection points and doses administered
- Apply ice pack for 5-10 minutes to reduce swelling
Onset, Duration, and Expected Results
Understanding the timeline of Innotox effects helps set realistic patient expectations and plan follow-up appointments.
| Timeline | Expected Changes | Patient Instructions |
|---|---|---|
| 0-3 days | Minimal visible changes, mild swelling possible | Avoid touching or massaging area |
| 3-7 days | Initial softening of wrinkles, reduced scrunching | Continue normal activities, avoid strenuous exercise |
| 7-14 days | Peak effect visible, optimal wrinkle reduction | Schedule follow-up if touch-up needed |
| 14-30 days | Full effect maintained, stable results | Results will gradually fade over coming months |
| 3-4 months | Gradual return of muscle function | Schedule next treatment session |
| 4-6 months | Complete return to baseline | Repeat treatment if desired |
Clinical Data: Studies have shown that nasal botulinum toxin treatments with botulinum toxin type A products demonstrate an efficacy rate of approximately 85-92% in reducing nasal dynamic wrinkles. Patient satisfaction rates typically range from 78-88% at the 4-week follow-up assessment. Duration of effect varies based on individual metabolism, dosage, and injection technique, with an average duration of 3-4 months.
Potential Side Effects and How to Manage Them
While nasal scrunch treatment with Innotox 100u is generally considered safe when performed by trained practitioners, awareness of potential side effects is crucial for both patient safety and satisfaction.
Common Side Effects (Mild, Self-Limiting)
- Injection site bruising: Occurs in approximately 15-20% of patients; apply ice immediately and arnica gel
- Mild swelling: Expected for 24-48 hours; typically resolves without intervention
- Transient headache: Reported by 5-10% of patients; can use mild analgesics if needed
- Slight asymmetry: May occur initially; often self-corrects within 2 weeks
Rare but Serious Complications
- Ptosis of the upper lip:
- Occurs if toxin diffuses to the levator labii superioris muscle
- Treatment: May require additional injections of the depressor muscles to compensate
- Resolution: Typically self-resolves as toxin effect fades
- Nasal tip drooping:
- Caused by over-treatment of depressor septi nasi muscle
- Prevention: Use conservative dosing and precise injection technique
- Management: Wait for natural resolution; typically 6-8 weeks
- Asymmetry of smile:
- Can occur if toxin affects surrounding facial muscles
- Risk factors: Poor injection technique, excessive dosing, or anatomical variation
- Treatment: May require compensatory injections or wait for effect to diminish
Post-Treatment Care Instructions for Patients
Providing clear post-treatment instructions significantly impacts treatment outcomes and patient satisfaction. The following guidelines should be communicated verbally and in written form.
- First 4 hours post-treatment:
- Remain upright; do not lie flat
- Avoid touching, rubbing, or applying pressure to treated areas
- Do not apply makeup or skincare products to the injection sites
- First 24 hours:
- Avoid strenuous exercise and activities that increase blood flow to the face
- Refrain from consuming excessive alcohol
- Avoid saunas, steam rooms, and hot baths
- Use cold compresses if swelling or discomfort occurs
- First 48-72 hours:
- Continue avoiding facial massages and treatments
- Avoid dental procedures if possible
- Be gentle when washing or applying products to the face
Emergency Contact: Patients should be instructed to contact their practitioner immediately if they experience difficulty breathing, swallowing, speaking, or any severe or unexpected reactions. While extremely rare, allergic reactions to botulinum toxin products can occur and require prompt medical attention.
Combining Nasal Scrunch Treatment with Other Procedures
Nasal scrunch treatment with Innotox 100u can be effectively combined with other aesthetic procedures to achieve more comprehensive facial rejuvenation. Understanding treatment sequencing and timing is essential for optimal outcomes.
| Combined Treatment | Recommended Sequence | Interval Between Treatments | Considerations |
|---|---|---|---|
| Dermal fillers (nasal bridge) | Filler first, then toxin | 2 weeks minimum | Allow filler to settle before assessing toxin effect |
| Laser treatments | Toxin first, then laser | 1 week before or after | Heat may accelerate toxin degradation |
| Chemical peels | Toxin first, then peel | 1-2 weeks before | Peel should not be applied to injection sites |
| Microneedling | Toxin first, then microneedling | 2 weeks after toxin | Needling may spread toxin if done too early |
Cost Considerations and Treatment Frequency
Understanding the cost structure helps practitioners set appropriate pricing and helps patients plan their treatment budget. Treatment costs vary based on geographic location, practitioner expertise, and clinic overhead.